CL2019003236A1 - Las sales de un compuesto y sus formas cristalinas. - Google Patents
Las sales de un compuesto y sus formas cristalinas.Info
- Publication number
- CL2019003236A1 CL2019003236A1 CL2019003236A CL2019003236A CL2019003236A1 CL 2019003236 A1 CL2019003236 A1 CL 2019003236A1 CL 2019003236 A CL2019003236 A CL 2019003236A CL 2019003236 A CL2019003236 A CL 2019003236A CL 2019003236 A1 CL2019003236 A1 CL 2019003236A1
- Authority
- CL
- Chile
- Prior art keywords
- compound
- salts
- crystalline forms
- forms
- metoxyquinazolin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
LA PRESENTE INVENCIÓN PERTENECE AL CAMPO FARMACÉUTICO Y PROPORCIONA EL COMPUESTO 4-ETIL-N- (4 - ((3-ETINIFENIL) AMINO) -7-METOXIQUINAZOLIN-6-IL) PIPERAZINA-L-CARBOXAMIDA SUCCINATO Y SUS FORMAS CRISTALINAS. , LOS SOLVATOS Y LAS FORMAS CRISTALINAS DE LOS MISMOS, LAS COMPOSICIONES FARMACÉUTICAS QUE COMPRENDEN LOS MISMOS, ASÍ COMO LOS MÉTODOS DE PREPARACIÓN DE LOS MISMOS Y EL USO DE LOS MISMOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710343882.5A CN108863951A (zh) | 2017-05-16 | 2017-05-16 | 化合物的盐及其晶型 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2019003236A1 true CL2019003236A1 (es) | 2020-03-13 |
Family
ID=64274088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2019003236A CL2019003236A1 (es) | 2017-05-16 | 2019-11-12 | Las sales de un compuesto y sus formas cristalinas. |
Country Status (14)
Country | Link |
---|---|
US (1) | US20210155611A1 (es) |
EP (1) | EP3630750A4 (es) |
JP (1) | JP2020520384A (es) |
KR (1) | KR20200006078A (es) |
CN (2) | CN108863951A (es) |
AU (1) | AU2018269083A1 (es) |
BR (1) | BR112019024033A2 (es) |
CA (1) | CA3062371A1 (es) |
CL (1) | CL2019003236A1 (es) |
EA (1) | EA201992708A1 (es) |
PE (1) | PE20200014A1 (es) |
PH (1) | PH12019502560A1 (es) |
TW (1) | TW201900636A (es) |
WO (1) | WO2018210255A1 (es) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101619043B (zh) * | 2008-06-30 | 2013-06-05 | 和记黄埔医药(上海)有限公司 | 喹唑啉衍生物及其医药用途 |
US8426430B2 (en) * | 2008-06-30 | 2013-04-23 | Hutchison Medipharma Enterprises Limited | Quinazoline derivatives |
-
2017
- 2017-05-16 CN CN201710343882.5A patent/CN108863951A/zh active Pending
-
2018
- 2018-05-16 AU AU2018269083A patent/AU2018269083A1/en not_active Abandoned
- 2018-05-16 WO PCT/CN2018/087047 patent/WO2018210255A1/en unknown
- 2018-05-16 CA CA3062371A patent/CA3062371A1/en not_active Abandoned
- 2018-05-16 JP JP2020514318A patent/JP2020520384A/ja active Pending
- 2018-05-16 KR KR1020197035822A patent/KR20200006078A/ko unknown
- 2018-05-16 BR BR112019024033-0A patent/BR112019024033A2/pt not_active Application Discontinuation
- 2018-05-16 EA EA201992708A patent/EA201992708A1/ru unknown
- 2018-05-16 TW TW107116601A patent/TW201900636A/zh unknown
- 2018-05-16 PE PE2019002410A patent/PE20200014A1/es unknown
- 2018-05-16 CN CN201880032022.2A patent/CN110650952A/zh active Pending
- 2018-05-16 US US16/614,029 patent/US20210155611A1/en not_active Abandoned
- 2018-05-16 EP EP18802326.1A patent/EP3630750A4/en not_active Withdrawn
-
2019
- 2019-11-12 CL CL2019003236A patent/CL2019003236A1/es unknown
- 2019-11-15 PH PH12019502560A patent/PH12019502560A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2018210255A9 (en) | 2019-07-04 |
EP3630750A1 (en) | 2020-04-08 |
PH12019502560A1 (en) | 2021-01-25 |
CA3062371A1 (en) | 2018-11-22 |
CN110650952A (zh) | 2020-01-03 |
US20210155611A1 (en) | 2021-05-27 |
CN108863951A (zh) | 2018-11-23 |
AU2018269083A1 (en) | 2019-11-21 |
EP3630750A4 (en) | 2020-09-30 |
BR112019024033A2 (pt) | 2020-06-02 |
WO2018210255A1 (en) | 2018-11-22 |
KR20200006078A (ko) | 2020-01-17 |
TW201900636A (zh) | 2019-01-01 |
JP2020520384A (ja) | 2020-07-09 |
PE20200014A1 (es) | 2020-01-06 |
EA201992708A1 (ru) | 2020-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2020003007A1 (es) | Lactamas biciclicas y metodos de uso de las mismas (divisional solicitud no. 3486-2017) | |
CO2021016018A2 (es) | Inhibidores de tead y usos de los mismos referencia cruzada a solicitudes relacionadas | |
AR109393A1 (es) | Un esteroide 19-nor-c21-pirazolilo c3,3-disustituido cristalino | |
CO2021016015A2 (es) | Inhibidores de tead y usos de los mismos referencia cruzada a solicitudes relacionadas | |
CO2019009373A2 (es) | Compuestos heterocíclicos útiles como inhibidores duales de atx/ca. | |
SV2016005312A (es) | Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cã�ncer | |
CO2018007443A2 (es) | Nuevos derivados de amonio, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
ECSP17039611A (es) | Derivados de quinazolina utilizados para tratar el vih | |
DOP2017000101A (es) | Formas cristalinas de 5-cloro-n4-[2-(dimetilfosforil)fenil]-n2-{2-metoxi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il]pirimidina-2,4-diamina | |
CR20190268A (es) | Nuevos deribados de isoxazolil éter como pam de gaba a alfa5 | |
UY37564A (es) | Aislados de lysinibacillus y usos de los mismos | |
UY32916A (es) | Nuevas pirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones | |
SV2016005330A (es) | Compuestos de 1,3,4-tiadiazol y uso de los mismos para el tratamiento del cã�ncer | |
CL2020000101A1 (es) | Compuestos de cetonas bicíclicas y métodos de uso de los mismos. | |
CO2021010930A2 (es) | Hidroxipiridoxazepinas como activadores de nrf2 | |
UY38031A (es) | Hidroxiisoxazolinas y derivados de estos | |
UY36110A (es) | Inhibidores de quinasa relacionados con tropomiosina | |
DOP2016000242A (es) | Uso de compuestos heterocíclicos para controlar nematodos | |
CL2018000731A1 (es) | Compuestos trifluoroalquenilo heterocíclicos con actividad nematicida, sus composiciones agronómicas y el uso de las mismas | |
UY38759A (es) | Tienilhidroxiisoxazolinas y derivados de las mismas | |
DOP2019000221A (es) | Derivados de pirazol como inhibidores de bromodominio | |
MX2020009022A (es) | Uso de alcoxipirazoles como inhibidores de la nitrificacion. | |
UY37968A (es) | Derivados del tetrazolilpropilo y su uso como fungicidas | |
CL2020002058A1 (es) | Piridincarboxamidas novedosas. | |
CL2019002840A1 (es) | Formas cristalinas de (s)-afoxolaner. |